Literature DB >> 850245

Quinazolines as inhibitors of dihydrofolate reductase. 4. Classical analogues of folic and isofolic acids.

J B Hynes, D E Eason, C M Garrett, P L Colvin.   

Abstract

A series of classical quinazoline analogues of folic and isofolic acids was evaluated for inhibitory activity against the dihydrofolate reductases from rat liver and from Streptococcus faecium. Included in this group were the known active antitumor agents methasquin and chlorasquin as well as methotrexate. Two new compounds, N10-formyl-5,8-deazaaminopterin and N10-formyl-5,8-deazafolic acid, were synthesized specifically for this study. The latter displayed modest activity against L1210 leukemia in mice.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 850245     DOI: 10.1021/jm00214a030

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  3 in total

1.  In vitro susceptibilities of Plasmodium falciparum to compounds which inhibit nucleotide metabolism.

Authors:  S A Queen; D L Jagt; P Reyes
Journal:  Antimicrob Agents Chemother       Date:  1990-07       Impact factor: 5.191

2.  Novel pyrrolo[2,3-d]pyrimidine antifolate TNP-351: cytotoxic effect on methotrexate-resistant CCRF-CEM cells and inhibition of transformylases of de novo purine biosynthesis.

Authors:  F Itoh; O Russello; H Akimoto; G P Beardsley
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

3.  Dihydrofolate reductases in some folate-requiring bacteria with low trimethoprim susceptibility.

Authors:  R L Then; H Riggenbach
Journal:  Antimicrob Agents Chemother       Date:  1978-07       Impact factor: 5.191

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.